Sglt-2 Inhibitors in Diabetic Type 2 Patients Nephroprotective Effects of (Empagliflozin)

Authors

  • Sadikova N.G Tashkent medical academy, Tashkent Uzbekistan
  • Najmutdinova D. K Tashkent medical academy, Tashkent Uzbekistan.
  • Urunbayeva D. A Tashkent medical academy, Tashkent Uzbekistan.
  • Alimova S. E Tashkent medical academy, Tashkent Uzbekistan.
  • Tillaboyev Sh.Sh Tashkent medical academy, Tashkent Uzbekistan

Keywords:

SGLT-2ingibitors, Diabetes Mellitus

Abstract

Study of the effect of SGLT-2ingibitors on kidney function in Diabetes Mellitus Type 2 patients

Downloads

Published

2023-11-06

How to Cite

Sadikova N.G, Najmutdinova D. K, Urunbayeva D. A, Alimova S. E, & Tillaboyev Sh.Sh. (2023). Sglt-2 Inhibitors in Diabetic Type 2 Patients Nephroprotective Effects of (Empagliflozin). Genius Repository, 26, 1–4. Retrieved from https://geniusrepo.net/index.php/1/article/view/277

Issue

Section

Articles